Literature DB >> 22178428

Low sensitivity for the metabolic syndrome to detect uric acid elevations in females and non-Hispanic-black male adolescents: an analysis of NHANES 1999-2006.

Mark D DeBoer1, Matthew J Gurka.   

Abstract

BACKGROUND: Uric acid is tightly linked to the metabolic syndrome (MetS) and among adults higher uric acid levels are associated with future risk for diabetes, cardiovascular disease, hypertension and renal disease.
OBJECTIVE: Evaluate the sensitivity of MetS to identify adolescents with elevated uric acid levels on a race/ethnicity and gender-specific basis.
METHODS: We evaluated 3296 male and female adolescents 12-19 y participating in the National Health and Nutrition Evaluation Survey 1999-06, comprised of 67.6% non-Hispanic whites, 15.1% non-Hispanic blacks, and 17.3% Hispanics. We used a definition of MetS modified for use in adolescents and evaluated the sensitivity of a diagnosis of MetS to identify individuals with uric acid elevations (approximately the 95th percentile of uric acid by gender among normal-weight adolescents).
RESULTS: When used as a screening test to identify individuals with uric acid elevations MetS performed more poorly among females (18.0%) than among males (37.0%) (p<0.001). Among males, MetS exhibited a lower sensitivity among non-Hispanic blacks (17.8%) compared to Hispanics (45.9%) (p<0.01) and non-Hispanic whites (37.4%) (p<0.05). There were no race/ethnicity differences in detecting elevated uric acid levels among females (non-Hispanic-white 15.5%, non-Hispanic-black 19.4%, Hispanic 26.5%, p>0.05).
CONCLUSION: Current criteria to diagnose MetS exhibit racial/ethnic and gender differences in the ability to identify adolescents with elevated uric acid levels, performing poorly among non-Hispanic-black males and among females. Given emerging data regarding the ability of uric acid elevations for predicting future disease, these data may have implications regarding the use of MetS as a marker of risk among all gender and racial/ethnic groups.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178428      PMCID: PMC3321243          DOI: 10.1016/j.atherosclerosis.2011.11.033

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 2.  Uric acid as a factor in the metabolic syndrome.

Authors:  Rodolfo Leão Borges; Artur Beltrame Ribeiro; Maria Teresa Zanella; Marcelo Costa Batista
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

Review 3.  Uric acid in heart disease: a new C-reactive protein?

Authors:  Eswar Krishnan; Jeremy Sokolove
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

4.  Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study.

Authors:  Arnold B Alper; Wei Chen; Lillian Yau; Sathanur R Srinivasan; Gerald S Berenson; L Lee Hamm
Journal:  Hypertension       Date:  2004-11-29       Impact factor: 10.190

5.  Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endothelial plasma markers in obese children: the impact of cardiovascular risk factors.

Authors:  Andreas Alexander Meyer; Günther Kundt; Michael Steiner; Peter Schuff-Werner; Wolfgang Kienast
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

6.  Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.

Authors:  Jacqueline M Dekker; Cynthia Girman; Thomas Rhodes; Giel Nijpels; Coen D A Stehouwer; Lex M Bouter; Robert J Heine
Journal:  Circulation       Date:  2005-08-02       Impact factor: 29.690

7.  Incidence of diabetes in youth in the United States.

Authors:  Dana Dabelea; Ronny A Bell; Ralph B D'Agostino; Giuseppina Imperatore; Judith M Johansen; Barbara Linder; Lenna L Liu; Beth Loots; Santica Marcovina; Elizabeth J Mayer-Davis; David J Pettitt; Beth Waitzfelder
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

8.  Adolescent overweight and future adult coronary heart disease.

Authors:  Kirsten Bibbins-Domingo; Pamela Coxson; Mark J Pletcher; James Lightwood; Lee Goldman
Journal:  N Engl J Med       Date:  2007-12-06       Impact factor: 91.245

9.  Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study.

Authors:  Francesca Viazzi; Giovanna Leoncini; Marina Vercelli; Giacomo Deferrari; Roberto Pontremoli
Journal:  Diabetes Care       Date:  2010-10-04       Impact factor: 19.112

10.  Association between serum uric acid and development of type 2 diabetes.

Authors:  Satoru Kodama; Kazumi Saito; Yoko Yachi; Mihoko Asumi; Ayumi Sugawara; Kumiko Totsuka; Aki Saito; Hirohito Sone
Journal:  Diabetes Care       Date:  2009-06-23       Impact factor: 19.112

View more
  17 in total

1.  The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.

Authors:  Abhishek Vishnu; Matthew J Gurka; Mark D DeBoer
Journal:  Atherosclerosis       Date:  2015-09-21       Impact factor: 5.162

2.  Ethnic differences in the link between insulin resistance and elevated ALT.

Authors:  Mark D Deboer; R Constance Wiener; Barrett H Barnes; Matthew J Gurka
Journal:  Pediatrics       Date:  2013-08-12       Impact factor: 7.124

Review 3.  Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.

Authors:  Jeremy P Middleton; R Constance Wiener; Barrett H Barnes; Matthew J Gurka; Mark D DeBoer
Journal:  Clin Pediatr (Phila)       Date:  2014-01-28       Impact factor: 1.168

4.  Trends in Metabolic Syndrome Severity and Lifestyle Factors Among Adolescents.

Authors:  Arthur M Lee; Matthew J Gurka; Mark D DeBoer
Journal:  Pediatrics       Date:  2016-02-09       Impact factor: 7.124

Review 5.  Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions.

Authors:  Mark D DeBoer
Journal:  Nutrition       Date:  2012-09-28       Impact factor: 4.008

6.  Longitudinal Associations of Metabolic Syndrome Severity Between Childhood and Young Adulthood: The Bogalusa Heart Study.

Authors:  Linda X Wang; Stephanie L Filipp; Elaine M Urbina; Matthew J Gurka; Mark D DeBoer
Journal:  Metab Syndr Relat Disord       Date:  2018-03-27       Impact factor: 1.894

7.  Correlation of metabolic syndrome severity with cardiovascular health markers in adolescents.

Authors:  Arthur M Lee; Matthew J Gurka; Mark D DeBoer
Journal:  Metabolism       Date:  2017-01-13       Impact factor: 8.694

8.  Severity of the metabolic syndrome as a predictor of type 2 diabetes between childhood and adulthood: the Princeton Lipid Research Cohort Study.

Authors:  Mark D DeBoer; Matthew J Gurka; Jessica G Woo; John A Morrison
Journal:  Diabetologia       Date:  2015-09-17       Impact factor: 10.122

9.  An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score.

Authors:  Matthew J Gurka; Christa L Lilly; M Norman Oliver; Mark D DeBoer
Journal:  Metabolism       Date:  2013-10-24       Impact factor: 8.694

10.  Positive association between perfluoroalkyl chemicals and hyperuricemia in children.

Authors:  Sarah Dee Geiger; Jie Xiao; Anoop Shankar
Journal:  Am J Epidemiol       Date:  2013-04-03       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.